What is it?

A unique and empowering Project, Shivom will enable DNA data donors to collaborate with revolutionary changemakers in biotechnology, healthcare industry, and government-ordained research institutes and contribute to an unprecedented era of medical marvels.

Official Explainer Video

Project Shivom Details

Blockchain Ethereum (ERC20)
Proof Type Not mineable
Team Location Munich, Germany
First Announced November 6, 2017

Main ICO Details

ICO Start Date Apr 16 | 12:00 am UTC
ICO End Date May 16 | 11:55 pm UTC
Soft Cap 15,000 ETH
Hard Cap 75,000 ETH
Total Supply 3,000,000,000 OMX
Investor Supply 990,000,000 OMX
ICO Conversion 1 ETH = 7,000 OMX
Supply Distribution 33% Token sale* 20% Reserve 3% Community 14% Founders 10% Advisors 20% Growth pool ----------- *All unsold tokens will be burnt.

Pre ICO Details

Registration Required
KYC Required
Pre-ICO Start Date Mar 15 | 12:00 am UTC
Pre-ICO End Date Mar 31 | 11:55 pm UTC

Project Shivom Founding Team

Registered Company Name Omix Ventures Private Ltd - South Quay, Douglas

Number of Team Members 30 Employees

Axel Schumacher

Co-Founder and CEO

Gourish Singla

Co-Founder & COO

Sally Eaves

Co-Founder & CMO

Per Lind

Co-Founder and CSO

Henry Ines

Chief Innovation Officer

Akash Gaurav

Co-Founder and CTO

Kumar Gaurav

Co-Founder & Chief Technology Advisor

Natalie Pankova

Chief Scientific Officer

Agam Kansal

Marketing Lead

Pierre Maarek

Investment Lead

Charles Leslie

Investment Lead

Ting Peng

Public Relations Manager